Dr Rheault joined Verona in January 2019 and is our Chief Development Officer.
Dr Rheault started her career over 20 years ago as a medicinal chemist at GlaxoSmithKline, leading successful cross-functional teams in drug discovery. She then moved on to global project leadership for early development projects, including portfolio and governance management, before transitioning into a leadership role in late-stage clinical development for inhaled respiratory products. Prior to joining Verona Pharma, Dr Rheault helped numerous small biopharma companies develop integrated R&D and commercial strategies to achieve meaningful value-building milestones as a strategic drug development leader at IQVIA. Dr Rheault received a PhD in organic chemistry from North Dakota State University and a Master of Public Health from the University of North Carolina.
